{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:57:07Z","timestamp":1794581827517,"version":"4.9.1"},"reference-count":152,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Provincial Medical and Health Science and Technology Program","award":["2023KY555"],"award-info":[{"award-number":["2023KY555"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02812-z","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:56:18Z","timestamp":1750467378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["m5C RNA methylation in cancer: from biological mechanism to clinical perspectives"],"prefix":"10.1186","volume":"30","author":[{"given":"Fang","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"key":"2812_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"2812_CR2","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.26355\/eurrev_201806_15270","volume":"22","author":"JJ Wang","year":"2018","unstructured":"Wang JJ, Lei KF, Han F. Tumor microenvironment: recent advances in various cancer treatments. Eur Rev Med Pharmacol Sci. 2018;22:3855\u201364. https:\/\/doi.org\/10.26355\/eurrev_201806_15270.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2812_CR3","doi-asserted-by":"publisher","first-page":"1482746","DOI":"10.3389\/fimmu.2024.1482746","volume":"15","author":"Y Ou","year":"2024","unstructured":"Ou Y, Liang S, Gao Q, Shang Y, Liang J, Zhang W, Liu S. Prognostic value of inflammatory markers NLR, PLR, LMR, dNLR, ANC in melanoma patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review. Front Immunol. 2024;15:1482746. https:\/\/doi.org\/10.3389\/fimmu.2024.1482746.","journal-title":"Front Immunol"},{"key":"2812_CR4","doi-asserted-by":"publisher","first-page":"929","DOI":"10.2174\/1874467215666220103111009","volume":"15","author":"S Altaf","year":"2022","unstructured":"Altaf S, Saleem F, Sher AA, Ali A. Potential therapeutic strategies to combat HCC. Curr Mol Pharmacol. 2022;15:929\u201342. https:\/\/doi.org\/10.2174\/1874467215666220103111009.","journal-title":"Curr Mol Pharmacol"},{"key":"2812_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030751","author":"MT Luiz","year":"2023","unstructured":"Luiz MT, Dutra JAP, Viegas JSR, de Ara\u00fajo JTC, Tavares Junior AG, Chorilli M. Hybrid magnetic lipid-based nanoparticles for cancer therapy. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15030751.","journal-title":"Pharmaceutics"},{"key":"2812_CR6","doi-asserted-by":"publisher","first-page":"1152402","DOI":"10.3389\/fonc.2023.1152402","volume":"13","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Kranjc Brezar S, Grigorieva EV, Skvortsova II. Editorial: Cancer cell reprogramming: impact on carcinogenesis and cancer progression. Front Oncol. 2023;13:1152402. https:\/\/doi.org\/10.3389\/fonc.2023.1152402.","journal-title":"Front Oncol"},{"key":"2812_CR7","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.cell.2024.02.041","volume":"187","author":"A Passaro","year":"2024","unstructured":"Passaro A, Al Bakir M, Hamilton EG, Diehn M, Andr\u00e9 F, Roy-Chowdhuri S, Mountzios G, Wistuba II, Swanton C, Peters S. Cancer biomarkers: emerging trends and clinical implications for personalized treatment. Cell. 2024;187:1617\u201335. https:\/\/doi.org\/10.1016\/j.cell.2024.02.041.","journal-title":"Cell"},{"key":"2812_CR8","doi-asserted-by":"publisher","first-page":"838","DOI":"10.2174\/1874467214666210126105345","volume":"14","author":"C Kishore","year":"2021","unstructured":"Kishore C. Epigenetic regulation and promising therapies in colorectal cancer. Curr Mol Pharmacol. 2021;14:838\u201352. https:\/\/doi.org\/10.2174\/1874467214666210126105345.","journal-title":"Curr Mol Pharmacol"},{"key":"2812_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-981-15-3449-2_1","volume":"1253","author":"L Zhang","year":"2020","unstructured":"Zhang L, Lu Q, Chang C. Epigenetics in health and disease. Adv Exp Med Biol. 2020;1253:3\u201355. https:\/\/doi.org\/10.1007\/978-981-15-3449-2_1.","journal-title":"Adv Exp Med Biol"},{"key":"2812_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063358","author":"Q Cao","year":"2024","unstructured":"Cao Q, Tian Y, Deng Z, Yang F, Chen E. Epigenetic alteration in colorectal cancer: potential diagnostic and prognostic implications. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25063358.","journal-title":"Int J Mol Sci"},{"key":"2812_CR11","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.gendis.2018.06.003","volume":"5","author":"M Fardi","year":"2018","unstructured":"Fardi M, Solali S, Farshdousti HM. Epigenetic mechanisms as a new approach in cancer treatment: An updated review. Genes Dis. 2018;5:304\u201311. https:\/\/doi.org\/10.1016\/j.gendis.2018.06.003.","journal-title":"Genes Dis"},{"key":"2812_CR12","doi-asserted-by":"publisher","first-page":"e70239","DOI":"10.1002\/ctm2.70239","volume":"15","author":"L Zhang","year":"2025","unstructured":"Zhang L, Li Y, Li L, Yao F, Cai M, Ye D, Qu Y. Detection, molecular function and mechanisms of m5C in cancer. Clin Transl Med. 2025;15:e70239. https:\/\/doi.org\/10.1002\/ctm2.70239.","journal-title":"Clin Transl Med"},{"key":"2812_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ynstr.2014.10.006","volume":"1","author":"GJ Boersma","year":"2015","unstructured":"Boersma GJ, Tamashiro KL. Individual differences in the effects of prenatal stress exposure in rodents. Neurobiol Stress. 2015;1:100\u20138. https:\/\/doi.org\/10.1016\/j.ynstr.2014.10.006.","journal-title":"Neurobiol Stress"},{"key":"2812_CR14","doi-asserted-by":"publisher","first-page":"1333737","DOI":"10.3389\/fpubh.2024.1333737","volume":"12","author":"U Nwanaji-Enwerem","year":"2024","unstructured":"Nwanaji-Enwerem U, McGeary JE, Grigsby-Toussaint DS. Greenspace, stress, and health: how is epigenetics involved? Front Public Health. 2024;12:1333737. https:\/\/doi.org\/10.3389\/fpubh.2024.1333737.","journal-title":"Front Public Health"},{"key":"2812_CR15","doi-asserted-by":"publisher","first-page":"1533940","DOI":"10.3389\/fimmu.2025.1533940","volume":"16","author":"M Li","year":"2025","unstructured":"Li M, Tian H. Zhuang Y and Zhang Z New insights into N6-methyladenosine in hepatocellular carcinoma immunotherapy. Front Immunol. 2025;16:1533940. https:\/\/doi.org\/10.3389\/fimmu.2025.1533940.","journal-title":"Front Immunol"},{"key":"2812_CR16","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1038\/s41467-022-29665-y","volume":"13","author":"H Shi","year":"2022","unstructured":"Shi H, Xu Y, Tian N, Yang M, Liang FS. Inducible and reversible RNA N(6)-methyladenosine editing. Nat Commun. 2022;13:1958. https:\/\/doi.org\/10.1038\/s41467-022-29665-y.","journal-title":"Nat Commun"},{"key":"2812_CR17","doi-asserted-by":"publisher","first-page":"114023","DOI":"10.1016\/j.biopha.2022.114023","volume":"157","author":"P Tabnak","year":"2023","unstructured":"Tabnak P, Ghasemi Y, Natami M, Khorram R, Ebrahimnezhad M. Role of m(6)A modification in dysregulation of Wnt\/\u03b2-catenin pathway in cancer. Biomed Pharmacother. 2023;157:114023. https:\/\/doi.org\/10.1016\/j.biopha.2022.114023.","journal-title":"Biomed Pharmacother"},{"key":"2812_CR18","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1038\/s41388-020-1303-7","volume":"39","author":"C Zhang","year":"2020","unstructured":"Zhang C, Huang S, Zhuang H, Ruan S, Zhou Z, Huang K, Ji F, Ma Z, Hou B, He X. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation. Oncogene. 2020;39:4507\u201318. https:\/\/doi.org\/10.1038\/s41388-020-1303-7.","journal-title":"Oncogene"},{"key":"2812_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12943-023-01780-4","volume":"22","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wei J, Feng L, Li O, Huang L, Zhou S, Xu Y, An K, Zhang Y, Chen R, He L, Wang Q, Wang H, Du Y, Liu R, Huang C, Zhang X, Yang YG, Kan Q, Tian X. Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2\/YBX1\/QSOX1 axis in EGFR-mutant non-small-cell lung cancer. Mol Cancer. 2023;22:81. https:\/\/doi.org\/10.1186\/s12943-023-01780-4.","journal-title":"Mol Cancer"},{"key":"2812_CR20","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1053\/j.gastro.2020.11.013","volume":"160","author":"H Chen","year":"2021","unstructured":"Chen H, Gao S, Liu W, Wong CC, Wu J, Wu J, Liu D, Gou H, Kang W, Zhai J, Li C, Su H, Wang S, Soares F, Han J, He HH, Yu J. RNA N(6)-methyladenosine methyltransferase METTL3 facilitates colorectal cancer by activating the m(6)A-GLUT1-mTORC1 axis and is a therapeutic target. Gastroenterology. 2021;160:1284-1300.e16. https:\/\/doi.org\/10.1053\/j.gastro.2020.11.013.","journal-title":"Gastroenterology"},{"key":"2812_CR21","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41556-019-0361-y","volume":"21","author":"X Chen","year":"2019","unstructured":"Chen X, Li A, Sun BF, Yang Y, Han YN, Yuan X, Chen RX, Wei WS, Liu Y, Gao CC, Chen YS, Zhang M, Ma XD, Liu ZW, Luo JH, Lyu C, Wang HL, Ma J, Zhao YL, Zhou FJ, Huang Y, Xie D, Yang YG. 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. Nat Cell Biol. 2019;21:978\u201390. https:\/\/doi.org\/10.1038\/s41556-019-0361-y.","journal-title":"Nat Cell Biol"},{"key":"2812_CR22","doi-asserted-by":"publisher","first-page":"111529","DOI":"10.1016\/j.cellsig.2024.111529","volume":"126","author":"N Lou","year":"2025","unstructured":"Lou N, Gu X, Fu L, Li J, Xue C. Significant roles of RNA 5-methylcytosine methylation in cancer. Cell Signal. 2025;126:111529. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111529.","journal-title":"Cell Signal"},{"key":"2812_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msaf008","author":"Z Li","year":"2025","unstructured":"Li Z, Mi K, Xu C. Most m5C modifications in mammalian mRNAs are nonadaptive. Mol Biol Evol. 2025. https:\/\/doi.org\/10.1093\/molbev\/msaf008.","journal-title":"Mol Biol Evol"},{"key":"2812_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/biom14070881","author":"F Li","year":"2024","unstructured":"Li F, Li W. Readers of RNA modification in cancer and their anticancer inhibitors. Biomolecules. 2024. https:\/\/doi.org\/10.3390\/biom14070881.","journal-title":"Biomolecules"},{"key":"2812_CR25","doi-asserted-by":"publisher","first-page":"816173","DOI":"10.3389\/fgene.2022.816173","volume":"13","author":"Y Huang","year":"2022","unstructured":"Huang Y, Huang C, Jiang X, Yan Y, Zhuang K, Liu F, Li P, Wen Y. Exploration of potential roles of m5C-related regulators in colon adenocarcinoma prognosis. Front Genet. 2022;13:816173. https:\/\/doi.org\/10.3389\/fgene.2022.816173.","journal-title":"Front Genet"},{"key":"2812_CR26","doi-asserted-by":"publisher","first-page":"844778","DOI":"10.3389\/fimmu.2022.844778","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, Wang N, Wu J, Gao X, Zhao H, Liu Z, Yan X, Dong J, Wang F, Ba Y, Ma S, Jin J, Du J, Ji H, Hu S. 5-methylcytosine related LncRNAs reveal immune characteristics, predict prognosis and oncology treatment outcome in lower-grade gliomas. Front Immunol. 2022;13:844778. https:\/\/doi.org\/10.3389\/fimmu.2022.844778.","journal-title":"Front Immunol"},{"key":"2812_CR27","doi-asserted-by":"publisher","first-page":"e2309840","DOI":"10.1002\/advs.202309840","volume":"11","author":"B Chen","year":"2024","unstructured":"Chen B, Deng Y, Hong Y, Fan L, Zhai X, Hu H, Yin S, Chen Q, Xie X, Ren X, Zhao J, Jiang C. Metabolic recoding of NSUN2-mediated m(5)C modification promotes the progression of colorectal cancer via the NSUN2\/YBX1\/m(5)C-ENO1 positive feedback loop. Adv Sci (Weinh). 2024;11:e2309840. https:\/\/doi.org\/10.1002\/advs.202309840.","journal-title":"Adv Sci (Weinh)"},{"key":"2812_CR28","doi-asserted-by":"publisher","first-page":"109055","DOI":"10.1016\/j.envint.2024.109055","volume":"192","author":"RK Zhang","year":"2024","unstructured":"Zhang RK, Li Y, Sun FL, Zhou ZH, Xie YX, Liu WJ, Wang W, Qiu JG, Jiang BH, Wang L. RNA methyltransferase NSUN2-mediated m5C methylation promotes Cr(VI)-induced malignant transformation and lung cancer by accelerating metabolism reprogramming. Environ Int. 2024;192:109055. https:\/\/doi.org\/10.1016\/j.envint.2024.109055.","journal-title":"Environ Int"},{"key":"2812_CR29","doi-asserted-by":"publisher","first-page":"e24303","DOI":"10.1002\/jcla.24303","volume":"36","author":"X Fang","year":"2022","unstructured":"Fang X, Miao C, Zeng T, Chu W, Zheng Y, Sun X, Yin X, Li Y. Role of m(5) C RNA methylation regulators in colorectal cancer prognosis and immune microenvironment. J Clin Lab Anal. 2022;36:e24303. https:\/\/doi.org\/10.1002\/jcla.24303.","journal-title":"J Clin Lab Anal"},{"key":"2812_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40364-020-00225-0","volume":"8","author":"C Xue","year":"2020","unstructured":"Xue C, Zhao Y, Li L. Advances in RNA cytosine-5 methylation: detection, regulatory mechanisms, biological functions and links to cancer. Biomark Res. 2020;8:43. https:\/\/doi.org\/10.1186\/s40364-020-00225-0.","journal-title":"Biomark Res"},{"key":"2812_CR31","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.21037\/tcr-24-103","volume":"13","author":"L Cheng","year":"2024","unstructured":"Cheng L, Wang C, Zhao D, Wu S. Narrative review of research progress of RNA m(5)C methylation in head and neck malignancies. Transl Cancer Res. 2024;13:5112\u201322. https:\/\/doi.org\/10.21037\/tcr-24-103.","journal-title":"Transl Cancer Res"},{"key":"2812_CR32","doi-asserted-by":"publisher","first-page":"7345","DOI":"10.1038\/s41598-025-91233-3","volume":"15","author":"C Zhang","year":"2025","unstructured":"Zhang C, Li J, Wang L, Yang P, Luo X. ALKBH1 knockdown promotes the growth, migration and invasion of HTR-8\/SVneo cells through regulating the m5C modification PSMD14. Sci Rep. 2025;15:7345. https:\/\/doi.org\/10.1038\/s41598-025-91233-3.","journal-title":"Sci Rep"},{"key":"2812_CR33","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13058-024-01847-0","volume":"26","author":"X Zhang","year":"2024","unstructured":"Zhang X, An K, Ge X, Sun Y, Wei J, Ren W, Wang H, Wang Y, Du Y, He L, Li O, Zhou S, Shi Y, Ren T, Yang YG, Kan Q, Tian X. NSUN2\/YBX1 promotes the progression of breast cancer by enhancing HGH1 mRNA stability through m(5)C methylation. Breast Cancer Res. 2024;26:94. https:\/\/doi.org\/10.1186\/s13058-024-01847-0.","journal-title":"Breast Cancer Res"},{"key":"2812_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cells9081758","author":"A Chellamuthu","year":"2020","unstructured":"Chellamuthu A, Gray SG. The RNA methyltransferase NSUN2 and its potential roles in cancer. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9081758.","journal-title":"Cells"},{"key":"2812_CR35","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12967-022-03427-2","volume":"20","author":"M Li","year":"2022","unstructured":"Li M, Tao Z, Zhao Y, Li L, Zheng J, Li Z, Chen X. 5-methylcytosine RNA methyltransferases and their potential roles in cancer. J Transl Med. 2022;20:214. https:\/\/doi.org\/10.1186\/s12967-022-03427-2.","journal-title":"J Transl Med"},{"key":"2812_CR36","doi-asserted-by":"publisher","first-page":"10695","DOI":"10.1093\/nar\/gkac817","volume":"50","author":"H Liao","year":"2022","unstructured":"Liao H, Gaur A, McConie H, Shekar A, Wang K, Chang JT, Breton G, Denicourt C. Human NOP2\/NSUN1 regulates ribosome biogenesis through non-catalytic complex formation with box C\/D snoRNPs. Nucleic Acids Res. 2022;50:10695\u2013716. https:\/\/doi.org\/10.1093\/nar\/gkac817.","journal-title":"Nucleic Acids Res"},{"key":"2812_CR37","doi-asserted-by":"publisher","first-page":"2263921","DOI":"10.1080\/15384047.2023.2263921","volume":"24","author":"S Yang","year":"2023","unstructured":"Yang S, Zhou D, Zhang C, Xiang J, Xi X. Function of m(5)C RNA methyltransferase NOP2 in high-grade serous ovarian cancer. Cancer Biol Ther. 2023;24:2263921. https:\/\/doi.org\/10.1080\/15384047.2023.2263921.","journal-title":"Cancer Biol Ther"},{"key":"2812_CR38","doi-asserted-by":"publisher","first-page":"7263","DOI":"10.1038\/s41467-021-27501-3","volume":"12","author":"J Blaze","year":"2021","unstructured":"Blaze J, Navickas A, Phillips HL, Heissel S, Plaza-Jennings A, Miglani S, Asgharian H, Foo M, Katanski CD, Watkins CP, Pennington ZT, Javidfar B, Espeso-Gil S, Rostandy B, Alwaseem H, Hahn CG, Molina H, Cai DJ, Pan T, Yao WD, Goodarzi H, Haghighi F, Akbarian S. Author Correction: Neuronal Nsun2 deficiency produces tRNA epitranscriptomic alterations and proteomic shifts impacting synaptic signaling and behavior. Nat Commun. 2021;12:7263. https:\/\/doi.org\/10.1038\/s41467-021-27501-3.","journal-title":"Nat Commun"},{"key":"2812_CR39","doi-asserted-by":"publisher","first-page":"8720","DOI":"10.1093\/nar\/gkz559","volume":"47","author":"L Van Haute","year":"2019","unstructured":"Van Haute L, Lee SY, McCann BJ, Powell CA, Bansal D, Vasiliauskait\u0117 L, Garone C, Shin S, Kim JS, Frye M, Gleeson JG, Miska EA, Rhee HW, Minczuk M. NSUN2 introduces 5-methylcytosines in mammalian mitochondrial tRNAs. Nucleic Acids Res. 2019;47:8720\u201333. https:\/\/doi.org\/10.1093\/nar\/gkz559.","journal-title":"Nucleic Acids Res"},{"key":"2812_CR40","doi-asserted-by":"publisher","first-page":"8734","DOI":"10.1093\/nar\/gkz575","volume":"47","author":"S Shinoda","year":"2019","unstructured":"Shinoda S, Kitagawa S, Nakagawa S, Wei FY, Tomizawa K, Araki K, Araki M, Suzuki T, Suzuki T. Mammalian NSUN2 introduces 5-methylcytidines into mitochondrial tRNAs. Nucleic Acids Res. 2019;47:8734\u201345. https:\/\/doi.org\/10.1093\/nar\/gkz575.","journal-title":"Nucleic Acids Res"},{"key":"2812_CR41","doi-asserted-by":"publisher","first-page":"6906","DOI":"10.1038\/s41388-020-01475-w","volume":"39","author":"Z Sun","year":"2020","unstructured":"Sun Z, Xue S, Zhang M, Xu H, Hu X, Chen S, Liu Y, Guo M, Cui H. Aberrant NSUN2-mediated m(5)C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma. Oncogene. 2020;39:6906\u201319. https:\/\/doi.org\/10.1038\/s41388-020-01475-w.","journal-title":"Oncogene"},{"key":"2812_CR42","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/s42003-024-06918-8","volume":"7","author":"M Yu","year":"2024","unstructured":"Yu M, Cai Z, Zhang J, Zhang Y, Fu J, Cui X. Aberrant NSUN2-mediated m5C modification of exosomal LncRNA MALAT1 induced RANKL-mediated bone destruction in multiple myeloma. Commun Biol. 2024;7:1249. https:\/\/doi.org\/10.1038\/s42003-024-06918-8.","journal-title":"Commun Biol"},{"key":"2812_CR43","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1128\/mcb.00243-14","volume":"34","author":"S Yuan","year":"2014","unstructured":"Yuan S, Tang H, Xing J, Fan X, Cai X, Li Q, Han P, Luo Y, Zhang Z, Jiang B, Dou Y, Gorospe M, Wang W. Methylation by NSun2 represses the levels and function of microRNA 125b. Mol Cell Biol. 2014;34:3630\u201341. https:\/\/doi.org\/10.1128\/mcb.00243-14.","journal-title":"Mol Cell Biol"},{"key":"2812_CR44","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/cr.2017.55","volume":"27","author":"X Yang","year":"2017","unstructured":"Yang X, Yang Y, Sun BF, Chen YS, Xu JW, Lai WY, Li A, Wang X, Bhattarai DP, Xiao W, Sun HY, Zhu Q, Ma HL, Adhikari S, Sun M, Hao YJ, Zhang B, Huang CM, Huang N, Jiang GB, Zhao YL, Wang HL, Sun YP, Yang YG. 5-methylcytosine promotes mRNA export - NSUN2 as the methyltransferase and ALYREF as an m(5)C reader. Cell Res. 2017;27:606\u201325. https:\/\/doi.org\/10.1038\/cr.2017.55.","journal-title":"Cell Res"},{"key":"2812_CR45","doi-asserted-by":"publisher","first-page":"e1466","DOI":"10.1002\/ctm2.1466","volume":"13","author":"P Li","year":"2023","unstructured":"Li P, Wang W, Zhou R, Ding Y, Li X. The m(5) C methyltransferase NSUN2 promotes codon-dependent oncogenic translation by stabilising tRNA in anaplastic thyroid cancer. Clin Transl Med. 2023;13:e1466. https:\/\/doi.org\/10.1002\/ctm2.1466.","journal-title":"Clin Transl Med"},{"key":"2812_CR46","doi-asserted-by":"publisher","first-page":"e1621","DOI":"10.1002\/ctm2.1621","volume":"14","author":"S Zou","year":"2024","unstructured":"Zou S, Huang Y, Yang Z, Zhang J, Meng M, Zhang Y, Feng J, Sun R, Li W, Wang W, L\u00f3pez JG, Fang L. NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization. Clin Transl Med. 2024;14:e1621. https:\/\/doi.org\/10.1002\/ctm2.1621.","journal-title":"Clin Transl Med"},{"key":"2812_CR47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41419-023-05646-x","volume":"14","author":"M Yang","year":"2023","unstructured":"Yang M, Wei R, Zhang S, Hu S, Liang X, Yang Z, Zhang C, Zhang Y, Cai L, Xie Y. NSUN2 promotes osteosarcoma progression by enhancing the stability of FABP5 mRNA via m(5)C methylation. Cell Death Dis. 2023;14:125. https:\/\/doi.org\/10.1038\/s41419-023-05646-x.","journal-title":"Cell Death Dis"},{"key":"2812_CR48","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1002\/jcb.25957","volume":"118","author":"Q Li","year":"2017","unstructured":"Li Q, Li X, Tang H, Jiang B, Dou Y, Gorospe M, Wang W. NSUN2-mediated m5C methylation and METTL3\/METTL14-mediated m6A methylation cooperatively enhance p21 translation. J Cell Biochem. 2017;118:2587\u201398. https:\/\/doi.org\/10.1002\/jcb.25957.","journal-title":"J Cell Biochem"},{"key":"2812_CR49","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/nchembio.2099","volume":"12","author":"S Nakano","year":"2016","unstructured":"Nakano S, Suzuki T, Kawarada L, Iwata H, Asano K, Suzuki T. NSUN3 methylase initiates 5-formylcytidine biogenesis in human mitochondrial tRNA(Met). Nat Chem Biol. 2016;12:546\u201351. https:\/\/doi.org\/10.1038\/nchembio.2099.","journal-title":"Nat Chem Biol"},{"key":"2812_CR50","doi-asserted-by":"publisher","first-page":"e1004110","DOI":"10.1371\/journal.pgen.1004110","volume":"10","author":"MD Metodiev","year":"2014","unstructured":"Metodiev MD, Sp\u00e5hr H, Loguercio Polosa P, Meharg C, Becker C, Altmueller J, Habermann B, Larsson NG, Ruzzenente B. NSUN4 is a dual function mitochondrial protein required for both methylation of 12S rRNA and coordination of mitoribosomal assembly. PLoS Genet. 2014;10:e1004110. https:\/\/doi.org\/10.1371\/journal.pgen.1004110.","journal-title":"PLoS Genet"},{"key":"2812_CR51","doi-asserted-by":"publisher","first-page":"217059","DOI":"10.1016\/j.canlet.2024.217059","volume":"597","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, Zhou Y, Lv P, Zhou T, Liu H, Xie Y, Wu Z, Wang X, Zhao H, Zheng J, Jiang X. NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilization. Cancer Lett. 2024;597:217059. https:\/\/doi.org\/10.1016\/j.canlet.2024.217059.","journal-title":"Cancer Lett"},{"key":"2812_CR52","doi-asserted-by":"publisher","first-page":"217266","DOI":"10.1016\/j.canlet.2024.217266","volume":"605","author":"J Wu","year":"2024","unstructured":"Wu J, Zhao Q, Chen S, Xu H, Zhang R, Cai D, Gao Y, Peng W, Chen X, Yuan S, Li D, Li G, Nan A. NSUN4-mediated m5C modification of circERI3 promotes lung cancer development by altering mitochondrial energy metabolism. Cancer Lett. 2024;605:217266. https:\/\/doi.org\/10.1016\/j.canlet.2024.217266.","journal-title":"Cancer Lett"},{"key":"2812_CR53","doi-asserted-by":"publisher","first-page":"11807","DOI":"10.1093\/nar\/gkz1043","volume":"47","author":"C Heissenberger","year":"2019","unstructured":"Heissenberger C, Liendl L, Nagelreiter F, Gonskikh Y, Yang G, Stelzer EM, Krammer TL, Micutkova L, Vogt S, Kreil DP, Sekot G, Siena E, Poser I, Harreither E, Linder A, Ehret V, Helbich TH, Grillari-Voglauer R, Jansen-D\u00fcrr P, Ko\u0161 M, Polacek N, Grillari J, Schosserer M. Loss of the ribosomal RNA methyltransferase NSUN5 impairs global protein synthesis and normal growth. Nucleic Acids Res. 2019;47:11807\u201325. https:\/\/doi.org\/10.1093\/nar\/gkz1043.","journal-title":"Nucleic Acids Res"},{"key":"2812_CR54","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/nar\/gkaa1193","volume":"49","author":"T Selmi","year":"2021","unstructured":"Selmi T, Hussain S, Dietmann S, Hei\u00df M, Borland K, Flad S, Carter JM, Dennison R, Huang YL, Kellner S, Bornel\u00f6v S, Frye M. Sequence- and structure-specific cytosine-5 mRNA methylation by NSUN6. Nucleic Acids Res. 2021;49:1006\u201322. https:\/\/doi.org\/10.1093\/nar\/gkaa1193.","journal-title":"Nucleic Acids Res"},{"key":"2812_CR55","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1261\/rna.051524.115","volume":"21","author":"S Haag","year":"2015","unstructured":"Haag S, Warda AS, Kretschmer J, G\u00fcnnigmann MA, H\u00f6bartner C, Bohnsack MT. NSUN6 is a human RNA methyltransferase that catalyzes formation of m5C72 in specific tRNAs. RNA. 2015;21:1532\u201343. https:\/\/doi.org\/10.1261\/rna.051524.115.","journal-title":"RNA"},{"key":"2812_CR56","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.celrep.2015.12.043","volume":"14","author":"F Aguilo","year":"2016","unstructured":"Aguilo F, Li S, Balasubramaniyan N, Sancho A, Benko S, Zhang F, Vashisht A, Rengasamy M, Andino B, Chen CH, Zhou F, Qian C, Zhou MM, Wohlschlegel JA, Zhang W, Suchy FJ, Walsh MJ. Deposition of 5-methylcytosine on enhancer RNAs enables the coactivator function of PGC-1\u03b1. Cell Rep. 2016;14:479\u201392. https:\/\/doi.org\/10.1016\/j.celrep.2015.12.043.","journal-title":"Cell Rep"},{"key":"2812_CR57","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1126\/science.1120976","volume":"311","author":"MG Goll","year":"2006","unstructured":"Goll MG, Kirpekar F, Maggert KA, Yoder JA, Hsieh CL, Zhang X, Golic KG, Jacobsen SE, Bestor TH. Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2. Science. 2006;311:395\u20138. https:\/\/doi.org\/10.1126\/science.1120976.","journal-title":"Science"},{"key":"2812_CR58","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1101\/gad.1960210","volume":"24","author":"DC Wallace","year":"2010","unstructured":"Wallace DC. The epigenome and the mitochondrion: bioenergetics and the environment [corrected]. Genes Dev. 2010;24:1571\u20133. https:\/\/doi.org\/10.1101\/gad.1960210.","journal-title":"Genes Dev"},{"key":"2812_CR59","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bbrc.2019.09.098","volume":"520","author":"S Xue","year":"2019","unstructured":"Xue S, Xu H, Sun Z, Shen H, Chen S, Ouyang J, Zhou Q, Hu X, Cui H. Depletion of TRDMT1 affects 5-methylcytosine modification of mRNA and inhibits HEK293 cell proliferation and migration. Biochem Biophys Res Commun. 2019;520:60\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2019.09.098.","journal-title":"Biochem Biophys Res Commun"},{"key":"2812_CR60","doi-asserted-by":"publisher","first-page":"e2304329","DOI":"10.1002\/advs.202304329","volume":"10","author":"K Wang","year":"2023","unstructured":"Wang K, Li FH, Zhou LY, Zhao XM, Gao XQ, Liu CY, Li XM, Chen XZ, Zhao Y, Cheng XL, Wang RQ, Li RF, Zhang YH, Gao F, Tian JW, Wang K. HNEAP regulates necroptosis of cardiomyocytes by suppressing the m(5) C methylation of Atf7 mRNA. Adv Sci (Weinh). 2023;10:e2304329. https:\/\/doi.org\/10.1002\/advs.202304329.","journal-title":"Adv Sci (Weinh)"},{"key":"2812_CR61","doi-asserted-by":"publisher","first-page":"729887","DOI":"10.3389\/fonc.2021.729887","volume":"11","author":"F Li","year":"2021","unstructured":"Li F, Deng Q, Pang X, Huang S, Zhang J, Zhu X, Chen H, Liu X. m(5)C regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in papillary thyroid carcinoma. Front Oncol. 2021;11:729887. https:\/\/doi.org\/10.3389\/fonc.2021.729887.","journal-title":"Front Oncol"},{"key":"2812_CR62","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.1038\/s41598-023-32452-4","volume":"13","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Hu Z, Sun Q, Dong Y. 5-methyladenosine regulators play a crucial role in development of chronic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis. Sci Rep. 2023;13:5941. https:\/\/doi.org\/10.1038\/s41598-023-32452-4.","journal-title":"Sci Rep"},{"key":"2812_CR63","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s12010-021-03537-5","volume":"193","author":"A Seethy","year":"2021","unstructured":"Seethy A, Pethusamy K, Chattopadhyay I, Sah R, Chopra A, Dhar R, Karmakar S. TETology: epigenetic mastermind in action. Appl Biochem Biotechnol. 2021;193:1701\u201326. https:\/\/doi.org\/10.1007\/s12010-021-03537-5.","journal-title":"Appl Biochem Biotechnol"},{"key":"2812_CR64","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.stem.2023.07.001","volume":"30","author":"Y Li","year":"2023","unstructured":"Li Y, Xue M, Deng X, Dong L, Nguyen LXT, Ren L, Han L, Li C, Xue J, Zhao Z, Li W, Qing Y, Shen C, Tan B, Chen Z, Leung K, Wang K, Swaminathan S, Li L, Wunderlich M, Mulloy JC, Li X, Chen H, Zhang B, Horne D, Rosen ST, Marcucci G, Xu M, Li Z, Wei M, Tian J, Shen B, Su R, Chen J. TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal. Cell Stem Cell. 2023;30:1072-1090.e10. https:\/\/doi.org\/10.1016\/j.stem.2023.07.001.","journal-title":"Cell Stem Cell"},{"key":"2812_CR65","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","volume":"170","author":"L Cimmino","year":"2017","unstructured":"Cimmino L, Dolgalev I, Wang Y, Yoshimi A, Martin GH, Wang J, Ng V, Xia B, Witkowski MT, Mitchell-Flack M, Grillo I, Bakogianni S, Ndiaye-Lobry D, Mart\u00edn MT, Guillamot M, Banh RS, Xu M, Figueroa ME, Dickins RA, Abdel-Wahab O, Park CY, Tsirigos A, Neel BG, Aifantis I. Restoration of TET2 function blocks aberrant self-renewal and leukemia progression. Cell. 2017;170:1079-1095.e20. https:\/\/doi.org\/10.1016\/j.cell.2017.07.032.","journal-title":"Cell"},{"key":"2812_CR66","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41586-024-07969-x","volume":"634","author":"Z Zou","year":"2024","unstructured":"Zou Z, Dou X, Li Y, Zhang Z, Wang J, Gao B, Xiao Y, Wang Y, Zhao L, Sun C, Liu Q, Yu X, Wang H, Hong J, Dai Q, Yang FC, Xu M, He C. RNA m(5)C oxidation by TET2 regulates chromatin state and leukaemogenesis. Nature. 2024;634:986\u201394. https:\/\/doi.org\/10.1038\/s41586-024-07969-x.","journal-title":"Nature"},{"key":"2812_CR67","doi-asserted-by":"publisher","first-page":"100087","DOI":"10.1074\/jbc.RA120.014226","volume":"296","author":"H Shen","year":"2021","unstructured":"Shen H, Ontiveros RJ, Owens MC, Liu MY, Ghanty U, Kohli RM, Liu KF. TET-mediated 5-methylcytosine oxidation in tRNA promotes translation. J Biol Chem. 2021;296:100087. https:\/\/doi.org\/10.1074\/jbc.RA120.014226.","journal-title":"J Biol Chem"},{"key":"2812_CR68","doi-asserted-by":"publisher","first-page":"e2116251119","DOI":"10.1073\/pnas.2116251119","volume":"119","author":"H Yang","year":"2022","unstructured":"Yang H, Wang Y, Xiang Y, Yadav T, Ouyang J, Phoon L, Zhu X, Shi Y, Zou L, Lan L. FMRP promotes transcription-coupled homologous recombination via facilitating TET1-mediated m5C RNA modification demethylation. Proc Natl Acad Sci U S A. 2022;119:e2116251119. https:\/\/doi.org\/10.1073\/pnas.2116251119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2812_CR69","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/cbic.201600328","volume":"18","author":"M Basanta-Sanchez","year":"2017","unstructured":"Basanta-Sanchez M, Wang R, Liu Z, Ye X, Li M, Shi X, Agris PF, Zhou Y, Huang Y, Sheng J. TET1-mediated oxidation of 5-formylcytosine (5fC) to 5-carboxycytosine (5caC) in RNA. ChemBioChem. 2017;18:72\u20136. https:\/\/doi.org\/10.1002\/cbic.201600328.","journal-title":"ChemBioChem"},{"key":"2812_CR70","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13046-016-0350-y","volume":"35","author":"Z Ye","year":"2016","unstructured":"Ye Z, Li J, Han X, Hou H, Chen H, Zheng X, Lu J, Wang L, Chen W, Li X, Zhao L. TET3 inhibits TGF-\u03b21-induced epithelial-mesenchymal transition by demethylating miR-30d precursor gene in ovarian cancer cells. J Exp Clin Cancer Res. 2016;35:72. https:\/\/doi.org\/10.1186\/s13046-016-0350-y.","journal-title":"J Exp Clin Cancer Res"},{"key":"2812_CR71","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1038\/s41467-022-31876-2","volume":"13","author":"AE Arguello","year":"2022","unstructured":"Arguello AE, Li A, Sun X, Eggert TW, Mairhofer E, Kleiner RE. Reactivity-dependent profiling of RNA 5-methylcytidine dioxygenases. Nat Commun. 2022;13:4176. https:\/\/doi.org\/10.1038\/s41467-022-31876-2.","journal-title":"Nat Commun"},{"key":"2812_CR72","doi-asserted-by":"publisher","first-page":"7401","DOI":"10.1093\/nar\/gkx354","volume":"45","author":"L Kawarada","year":"2017","unstructured":"Kawarada L, Suzuki T, Ohira T, Hirata S, Miyauchi K, Suzuki T. ALKBH1 is an RNA dioxygenase responsible for cytoplasmic and mitochondrial tRNA modifications. Nucleic Acids Res. 2017;45:7401\u201315. https:\/\/doi.org\/10.1093\/nar\/gkx354.","journal-title":"Nucleic Acids Res"},{"key":"2812_CR73","doi-asserted-by":"publisher","first-page":"920164","DOI":"10.3389\/fgene.2022.920164","volume":"13","author":"H Ren","year":"2022","unstructured":"Ren H, Liu C, Wu H, Wang Z, Chen S, Zhang X, Ren J, Qiu H, Zhou L. m(5)C Regulator-mediated methylation modification clusters contribute to the immune microenvironment regulation of multiple myeloma. Front Genet. 2022;13:920164. https:\/\/doi.org\/10.3389\/fgene.2022.920164.","journal-title":"Front Genet"},{"key":"2812_CR74","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/mc.23418","volume":"62","author":"M Verghese","year":"2023","unstructured":"Verghese M, Wilkinson E, He YY. Role of RNA modifications in carcinogenesis and carcinogen damage response. Mol Carcinog. 2023;62:24\u201337. https:\/\/doi.org\/10.1002\/mc.23418.","journal-title":"Mol Carcinog"},{"key":"2812_CR75","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41698-024-00737-0","volume":"8","author":"L Zhong","year":"2024","unstructured":"Zhong L, Wu J, Zhou B, Kang J, Wang X, Ye F, Lin X. ALYREF recruits ELAVL1 to promote colorectal tumorigenesis via facilitating RNA m5C recognition and nuclear export. NPJ Precis Oncol. 2024;8:243. https:\/\/doi.org\/10.1038\/s41698-024-00737-0.","journal-title":"NPJ Precis Oncol"},{"key":"2812_CR76","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41419-024-06959-1","volume":"15","author":"Y Jin","year":"2024","unstructured":"Jin Y, Yao J, Fu J, Huang Q, Luo Y, You Y, Zhang W, Zhong Q, Xia T, Xia L. ALYREF promotes the metastasis of nasopharyngeal carcinoma by increasing the stability of NOTCH1 mRNA. Cell Death Dis. 2024;15:578. https:\/\/doi.org\/10.1038\/s41419-024-06959-1.","journal-title":"Cell Death Dis"},{"key":"2812_CR77","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/cac2.12158","volume":"41","author":"JZ Wang","year":"2021","unstructured":"Wang JZ, Zhu W, Han J, Yang X, Zhou R, Lu HC, Yu H, Yuan WB, Li PC, Tao J, Lu Q, Wei JF, Yang H. The role of the HIF-1\u03b1\/ALYREF\/PKM2 axis in glycolysis and tumorigenesis of bladder cancer. Cancer Commun (Lond). 2021;41:560\u201375. https:\/\/doi.org\/10.1002\/cac2.12158.","journal-title":"Cancer Commun (Lond)"},{"key":"2812_CR78","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12943-023-01814-x","volume":"22","author":"Q Yang","year":"2023","unstructured":"Yang Q, Wang M, Xu J, Yu D, Li Y, Chen Y, Zhang X, Zhang J, Gu J, Zhang X. LINC02159 promotes non-small cell lung cancer progression via ALYREF\/YAP1 signaling. Mol Cancer. 2023;22:122. https:\/\/doi.org\/10.1186\/s12943-023-01814-x.","journal-title":"Mol Cancer"},{"key":"2812_CR79","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41419-023-06008-3","volume":"14","author":"T Yu","year":"2023","unstructured":"Yu T, Zhang Q, Yu SK, Nie FQ, Zhang ML, Wang Q, Lu KH. THOC3 interacts with YBX1 to promote lung squamous cell carcinoma progression through PFKFB4 mRNA modification. Cell Death Dis. 2023;14:475. https:\/\/doi.org\/10.1038\/s41419-023-06008-3.","journal-title":"Cell Death Dis"},{"key":"2812_CR80","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s12276-024-01184-4","volume":"56","author":"X Liu","year":"2024","unstructured":"Liu X, Wei Q, Yang C, Zhao H, Xu J, Mobet Y, Luo Q, Yang D, Zuo X, Chen N, Yang Y, Li L, Wang W, Yu J, Xu J, Liu T, Yi P. RNA m(5)C modification upregulates E2F1 expression in a manner dependent on YBX1 phase separation and promotes tumor progression in ovarian cancer. Exp Mol Med. 2024;56:600\u201315. https:\/\/doi.org\/10.1038\/s12276-024-01184-4.","journal-title":"Exp Mol Med"},{"key":"2812_CR81","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40364-022-00362-8","volume":"10","author":"H Song","year":"2022","unstructured":"Song H, Zhang J, Liu B, Xu J, Cai B, Yang H, Straube J, Yu X, Ma T. Biological roles of RNA m(5)C modification and its implications in cancer immunotherapy. Biomark Res. 2022;10:15. https:\/\/doi.org\/10.1186\/s40364-022-00362-8.","journal-title":"Biomark Res"},{"key":"2812_CR82","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.gpb.2022.09.007","volume":"21","author":"D Song","year":"2023","unstructured":"Song D, An K, Zhai W, Feng L, Xu Y, Sun R, Wang Y, Yang YG, Kan Q, Tian X. NSUN2-mediated mRNA m(5)C modification regulates the progression of hepatocellular carcinoma. Genomics Proteomics Bioinform. 2023;21:823\u201333. https:\/\/doi.org\/10.1016\/j.gpb.2022.09.007.","journal-title":"Genomics Proteomics Bioinform"},{"key":"2812_CR83","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s12967-025-06217-8","volume":"23","author":"F Li","year":"2025","unstructured":"Li F, Liu T, Dong Y, Gao Q, Lu R, Deng Z. 5-Methylcytosine RNA modification and its roles in cancer and cancer chemotherapy resistance. J Transl Med. 2025;23:390. https:\/\/doi.org\/10.1186\/s12967-025-06217-8.","journal-title":"J Transl Med"},{"key":"2812_CR84","doi-asserted-by":"publisher","first-page":"1533148","DOI":"10.3389\/fcell.2025.1533148","volume":"13","author":"X Hu","year":"2025","unstructured":"Hu X, Liu Y, Zhang S, Liu K, Gu X. The multifaceted role of m5C RNA methylation in digestive system tumorigenesis. Front Cell Dev Biol. 2025;13:1533148. https:\/\/doi.org\/10.3389\/fcell.2025.1533148.","journal-title":"Front Cell Dev Biol"},{"key":"2812_CR85","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1038\/s41388-024-03184-0","volume":"43","author":"H Xing","year":"2024","unstructured":"Xing H, Gu X, Liu Y, Xu L, He Y, Xue C. NSUN2 regulates Wnt signaling pathway depending on the m5C RNA modification to promote the progression of hepatocellular carcinoma. Oncogene. 2024;43:3469\u201382. https:\/\/doi.org\/10.1038\/s41388-024-03184-0.","journal-title":"Oncogene"},{"key":"2812_CR86","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41419-021-04127-3","volume":"12","author":"Y Hu","year":"2021","unstructured":"Hu Y, Chen C, Tong X, Chen S, Hu X, Pan B, Sun X, Chen Z, Shi X, Hu Y, Shen X, Xue X, Lu M. NSUN2 modified by SUMO-2\/3 promotes gastric cancer progression and regulates mRNA m5C methylation. Cell Death Dis. 2021;12:842. https:\/\/doi.org\/10.1038\/s41419-021-04127-3.","journal-title":"Cell Death Dis"},{"key":"2812_CR87","doi-asserted-by":"publisher","unstructured":"Liu L, Chen Y, Zhang T, Cui G, Wang W, Zhang G, Li J, Zhang Y, Wang Y, Zou Y, Ren Z, Xue W and Sun R. YBX1 Promotes Esophageal Squamous Cell Carcinoma Progression via m5C\u2010Dependent SMOX mRNA Stabilization. Adv Sci (Weinh) 2024; 11: e2302379. https:\/\/doi.org\/10.1002\/advs.202302379","DOI":"10.1002\/advs.202302379"},{"key":"2812_CR88","doi-asserted-by":"publisher","first-page":"5814","DOI":"10.1038\/s41388-021-01978-0","volume":"40","author":"J Su","year":"2021","unstructured":"Su J, Wu G, Ye Y, Zhang J, Zeng L, Huang X, Zheng Y, Bai R, Zhuang L, Li M, Pan L, Deng J, Li R, Deng S, Zhang S, Zuo Z, Liu Z, Lin J, Lin D, Zheng J. NSUN2-mediated RNA 5-methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B-dependent GRB2 mRNA stabilization. Oncogene. 2021;40:5814\u201328. https:\/\/doi.org\/10.1038\/s41388-021-01978-0.","journal-title":"Oncogene"},{"key":"2812_CR89","doi-asserted-by":"publisher","first-page":"0184","DOI":"10.34133\/research.0184","volume":"6","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhai X, Liu Y, Xia Z, Xia T, Du G, Zhou H, Franziska Strohmer D, Bazhin AV, Li Z, Wang X, Jin B, Guo D. NOP2-mediated m5C modification of c-Myc in an EIF3A-dependent manner to reprogram glucose metabolism and promote hepatocellular carcinoma progression. Research. 2023;6:0184. https:\/\/doi.org\/10.34133\/research.0184.","journal-title":"Research"},{"key":"2812_CR90","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-024-01777-5","volume":"9","author":"WW Liu","year":"2024","unstructured":"Liu WW, Zheng SQ, Li T, Fei YF, Wang C, Zhang S, Wang F, Jiang GM, Wang H. RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy. Signal Transduct Target Ther. 2024;9:70. https:\/\/doi.org\/10.1038\/s41392-024-01777-5.","journal-title":"Signal Transduct Target Ther"},{"key":"2812_CR91","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.7150\/ijbs.97503","volume":"20","author":"J Tian","year":"2024","unstructured":"Tian J, Gao J, Cheng C, Xu Z, Chen X, Wu Y, Fu G, Jin B. NOP2-mediated 5-methylcytosine modification of APOL1 messenger RNA activates PI3K-Akt and facilitates clear cell renal cell carcinoma progression. Int J Biol Sci. 2024;20:4853\u201371. https:\/\/doi.org\/10.7150\/ijbs.97503.","journal-title":"Int J Biol Sci"},{"key":"2812_CR92","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41419-025-07414-5","volume":"16","author":"Q Qi","year":"2025","unstructured":"Qi Q, Zhong R, Huang Y, Tang Y, Zhang XW, Liu C, Gao CF, Zhou L, Yu J, Wu LY. The RNA M5C methyltransferase NSUN2 promotes progression of hepatocellular carcinoma by enhancing PKM2-mediated glycolysis. Cell Death Dis. 2025;16:82. https:\/\/doi.org\/10.1038\/s41419-025-07414-5.","journal-title":"Cell Death Dis"},{"key":"2812_CR93","doi-asserted-by":"publisher","first-page":"117064","DOI":"10.1016\/j.ecoenv.2024.117064","volume":"285","author":"R Li","year":"2024","unstructured":"Li R, Li S, Shen L, Li J, Zhang D, Yu J, Huang L, Liu N, Lu H, Xu M. LINC00618 facilitates growth and metastasis of hepatocellular carcinoma via elevating cholesterol synthesis by promoting NSUN2-mediated SREBP2 m5C modification. Ecotoxicol Environ Saf. 2024;285:117064. https:\/\/doi.org\/10.1016\/j.ecoenv.2024.117064.","journal-title":"Ecotoxicol Environ Saf"},{"key":"2812_CR94","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41419-023-06049-8","volume":"14","author":"L Fang","year":"2023","unstructured":"Fang L, Huang H, Lv J, Chen Z, Lu C, Jiang T, Xu P, Li Y, Wang S, Li B, Li Z, Wang W, Xu Z. m5C-methylated lncRNA NR_033928 promotes gastric cancer proliferation by stabilizing GLS mRNA to promote glutamine metabolism reprogramming. Cell Death Dis. 2023;14:520. https:\/\/doi.org\/10.1038\/s41419-023-06049-8.","journal-title":"Cell Death Dis"},{"key":"2812_CR95","doi-asserted-by":"publisher","first-page":"e70023","DOI":"10.1111\/1759-7714.70023","volume":"16","author":"Z Li","year":"2025","unstructured":"Li Z, Wu X. NSUN4 facilitates the activity of oncogenic protein CDC20 to promote NSCLC development by mediating m5C modification of CDC20 mRNA. Thorac Cancer. 2025;16:e70023. https:\/\/doi.org\/10.1111\/1759-7714.70023.","journal-title":"Thorac Cancer"},{"key":"2812_CR96","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41419-020-2487-z","volume":"11","author":"L Mei","year":"2020","unstructured":"Mei L, Shen C, Miao R, Wang JZ, Cao MD, Zhang YS, Shi LH, Zhao GH, Wang MH, Wu LS, Wei JF. RNA methyltransferase NSUN2 promotes gastric cancer cell proliferation by repressing p57(Kip2) by an m(5)C-dependent manner. Cell Death Dis. 2020;11:270. https:\/\/doi.org\/10.1038\/s41419-020-2487-z.","journal-title":"Cell Death Dis"},{"key":"2812_CR97","first-page":"3858","volume":"12","author":"Z Jiang","year":"2020","unstructured":"Jiang Z, Li S, Han MJ, Hu GM, Cheng P. High expression of NSUN5 promotes cell proliferation via cell cycle regulation in colorectal cancer. Am J Transl Res. 2020;12:3858\u201370.","journal-title":"Am J Transl Res"},{"key":"2812_CR98","doi-asserted-by":"publisher","first-page":"e2309903","DOI":"10.1002\/advs.202309903","volume":"11","author":"W Tian","year":"2024","unstructured":"Tian W, Zhu L, Luo Y, Tang Y, Tan Q, Zou Y, Chen K, Deng X, Tang H, Li H, Cai M, Xie X, Ye F. Autophagy deficiency induced by SAT1 potentiates tumor progression in triple-negative breast cancer. Adv Sci (Weinh). 2024;11:e2309903. https:\/\/doi.org\/10.1002\/advs.202309903.","journal-title":"Adv Sci (Weinh)"},{"key":"2812_CR99","doi-asserted-by":"publisher","first-page":"141528","DOI":"10.1016\/j.ijbiomac.2025.141528","volume":"306","author":"S Chen","year":"2025","unstructured":"Chen S, Cai D, Zhao Q, Wu J, Zhou X, Xu H, Li X, Zhang R, Peng W, Li G, Nan A. NSUN2-mediated m5C modification of circFAM190B promotes lung cancer progression by inhibiting cellular autophagy. Int J Biol Macromol. 2025;306:141528. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.141528.","journal-title":"Int J Biol Macromol"},{"key":"2812_CR100","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41420-023-01521-y","volume":"9","author":"G Zhang","year":"2023","unstructured":"Zhang G, Liu L, Li J, Chen Y, Wang Y, Zhang Y, Dong Z, Xue W, Sun R, Cui G. NSUN2 stimulates tumor progression via enhancing TIAM2 mRNA stability in pancreatic cancer. Cell Death Discov. 2023;9:219. https:\/\/doi.org\/10.1038\/s41420-023-01521-y.","journal-title":"Cell Death Discov"},{"key":"2812_CR101","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41419-024-06899-w","volume":"15","author":"Y Yang","year":"2024","unstructured":"Yang Y, Fan H, Liu H, Lou X, Xiao N, Zhang C, Chen H, Chen S, Gu H, Liu H, Wan J. NOP2 facilitates EZH2-mediated epithelial-mesenchymal transition by enhancing EZH2 mRNA stability via m5C methylation in lung cancer progression. Cell Death Dis. 2024;15:506. https:\/\/doi.org\/10.1038\/s41419-024-06899-w.","journal-title":"Cell Death Dis"},{"key":"2812_CR102","doi-asserted-by":"publisher","first-page":"331","DOI":"10.7150\/ijbs.82316","volume":"20","author":"J Nulali","year":"2024","unstructured":"Nulali J, Zhang K, Long M, Wan Y, Liu Y, Zhang Q, Yang L, Hao J, Yang L, Song H. ALYREF-mediated RNA 5-methylcytosine modification promotes hepatocellular carcinoma progression via stabilizing EGFR mRNA and pSTAT3 activation. Int J Biol Sci. 2024;20:331\u201346. https:\/\/doi.org\/10.7150\/ijbs.82316.","journal-title":"Int J Biol Sci"},{"key":"2812_CR103","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2023.5585","author":"S Yang","year":"2023","unstructured":"Yang S, Zou R, Dai Y, Hu Y, Li F, Hu H. Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review). Int J Oncol. 2023. https:\/\/doi.org\/10.3892\/ijo.2023.5585.","journal-title":"Int J Oncol"},{"key":"2812_CR104","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12951-020-00741-z","volume":"18","author":"A Bahreyni","year":"2020","unstructured":"Bahreyni A, Mohamud Y, Luo H. Emerging nanomedicines for effective breast cancer immunotherapy. J Nanobiotechnol. 2020;18:180. https:\/\/doi.org\/10.1186\/s12951-020-00741-z.","journal-title":"J Nanobiotechnol"},{"key":"2812_CR105","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12943-024-01973-5","volume":"23","author":"A Zingoni","year":"2024","unstructured":"Zingoni A, Antonangeli F, Sozzani S, Santoni A, Cippitelli M, Soriani A. The senescence journey in cancer immunoediting. Mol Cancer. 2024;23:68. https:\/\/doi.org\/10.1186\/s12943-024-01973-5.","journal-title":"Mol Cancer"},{"key":"2812_CR106","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.semcancer.2021.03.002","volume":"78","author":"R Desai","year":"2022","unstructured":"Desai R, Coxon AT, Dunn GP. Therapeutic applications of the cancer immunoediting hypothesis. Semin Cancer Biol. 2022;78:63\u201377. https:\/\/doi.org\/10.1016\/j.semcancer.2021.03.002.","journal-title":"Semin Cancer Biol"},{"key":"2812_CR107","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41392-022-01175-9","volume":"7","author":"L Cui","year":"2022","unstructured":"Cui L, Ma R, Cai J, Guo C, Chen Z, Yao L, Wang Y, Fan R, Wang X, Shi Y. RNA modifications: importance in immune cell biology and related diseases. Signal Transduct Target Ther. 2022;7:334. https:\/\/doi.org\/10.1038\/s41392-022-01175-9.","journal-title":"Signal Transduct Target Ther"},{"key":"2812_CR108","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12943-024-02041-8","volume":"23","author":"Y Li","year":"2024","unstructured":"Li Y, Jin H, Li Q, Shi L, Mao Y, Zhao L. The role of RNA methylation in tumor immunity and its potential in immunotherapy. Mol Cancer. 2024;23:130. https:\/\/doi.org\/10.1186\/s12943-024-02041-8.","journal-title":"Mol Cancer"},{"key":"2812_CR109","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006401","author":"MM Melssen","year":"2023","unstructured":"Melssen MM, Sheybani ND, Leick KM, Slingluff CL. Barriers to immune cell infiltration in tumors. J Immunother Cancer. 2023. https:\/\/doi.org\/10.1136\/jitc-2022-006401.","journal-title":"J Immunother Cancer"},{"key":"2812_CR110","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006773","author":"GT Clifton","year":"2023","unstructured":"Clifton GT, Rothenberg M, Ascierto PA, Begley G, Cecchini M, Eder JP, Ghiringhelli F, Italiano A, Kochetkova M, Li R, Mechta-Grigoriou F, Pai SI, Provenzano P, Pur\u00e9 E, Ribas A, Schalper KA, Fridman WH. Developing a definition of immune exclusion in cancer: results of a modified Delphi workshop. J Immunother Cancer. 2023. https:\/\/doi.org\/10.1136\/jitc-2023-006773.","journal-title":"J Immunother Cancer"},{"key":"2812_CR111","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/odi.14357","volume":"30","author":"S Jin","year":"2024","unstructured":"Jin S, Li J, Shen Y, Wu Y, Zhang Z, Ma H. RNA 5-methylcytosine regulator NSUN3 promotes tumor progression through regulating immune infiltration in head and neck squamous cell carcinoma. Oral Dis. 2024;30:313\u201328. https:\/\/doi.org\/10.1111\/odi.14357.","journal-title":"Oral Dis"},{"key":"2812_CR112","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41423-024-01232-z","volume":"21","author":"J Kzhyshkowska","year":"2024","unstructured":"Kzhyshkowska J, Shen J, Larionova I. Targeting of TAMs: can we be more clever than cancer cells? Cell Mol Immunol. 2024;21:1376\u2013409. https:\/\/doi.org\/10.1038\/s41423-024-01232-z.","journal-title":"Cell Mol Immunol"},{"key":"2812_CR113","doi-asserted-by":"publisher","first-page":"1517959","DOI":"10.3389\/fimmu.2025.1517959","volume":"16","author":"J Yu","year":"2025","unstructured":"Yu J, Fu L, Wu R, Che L, Liu G, Ran Q, Xia Z, Liang X, Zhao G. Immunocytes in the tumor microenvironment: recent updates and interconnections. Front Immunol. 2025;16:1517959. https:\/\/doi.org\/10.3389\/fimmu.2025.1517959.","journal-title":"Front Immunol"},{"key":"2812_CR114","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1111\/jcmm.17826","volume":"27","author":"D Yan","year":"2023","unstructured":"Yan D, Xie Y, Huang L, Zhang Y, Gu R, Xie H, Huang X, Luo H. RNA m5C methylation orchestrates BLCA progression via macrophage reprogramming. J Cell Mol Med. 2023;27:2398\u2013411. https:\/\/doi.org\/10.1111\/jcmm.17826.","journal-title":"J Cell Mol Med"},{"key":"2812_CR115","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1158\/2326-6066.Cir-20-0729","volume":"9","author":"H Ruan","year":"2021","unstructured":"Ruan H, Bao L, Tao Z, Chen K. Flightless I. Homolog reverses enzalutamide resistance through PD-L1-mediated immune evasion in prostate cancer. Cancer Immunol Res. 2021;9:838\u201352. https:\/\/doi.org\/10.1158\/2326-6066.Cir-20-0729.","journal-title":"Cancer Immunol Res"},{"key":"2812_CR116","doi-asserted-by":"publisher","first-page":"788801","DOI":"10.3389\/fonc.2022.788801","volume":"12","author":"X Tong","year":"2022","unstructured":"Tong X, Xiang Y, Hu Y, Hu Y, Li H, Wang H, Zhao KN, Xue X, Zhu S. NSUN2 promotes tumor progression and regulates immune infiltration in nasopharyngeal carcinoma. Front Oncol. 2022;12:788801. https:\/\/doi.org\/10.3389\/fonc.2022.788801.","journal-title":"Front Oncol"},{"key":"2812_CR117","doi-asserted-by":"publisher","first-page":"657466","DOI":"10.3389\/fonc.2021.657466","volume":"11","author":"J Pan","year":"2021","unstructured":"Pan J, Huang Z, Xu Y. m5C RNA methylation regulators predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma. Front Oncol. 2021;11:657466. https:\/\/doi.org\/10.3389\/fonc.2021.657466.","journal-title":"Front Oncol"},{"key":"2812_CR118","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.1038\/s41586-019-1046-1","volume":"568","author":"D Han","year":"2019","unstructured":"Han D, Liu J, Chen C, Dong L, Liu Y, Chang R, Huang X, Liu Y, Wang J, Dougherty U, Bissonnette MB, Shen B, Weichselbaum RR, Xu MM, He C. Author Correction: Anti-tumour immunity controlled through mRNA m(6)A methylation and YTHDF1 in dendritic cells. Nature. 2019;568:E3. https:\/\/doi.org\/10.1038\/s41586-019-1046-1.","journal-title":"Nature"},{"key":"2812_CR119","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s10495-023-01885-7","volume":"29","author":"Y Wang","year":"2024","unstructured":"Wang Y, Jin P, Wang X. N(6)-methyladenosine regulator YTHDF1 represses the CD8 + T cell-mediated antitumor immunity and ferroptosis in prostate cancer via m(6)A\/PD-L1 manner. Apoptosis. 2024;29:142\u201353. https:\/\/doi.org\/10.1007\/s10495-023-01885-7.","journal-title":"Apoptosis"},{"key":"2812_CR120","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10495-023-01893-7","volume":"29","author":"Y Peng","year":"2024","unstructured":"Peng Y, Zhang Z, Yang G, Dai Z, Cai X, Liu Z, Yun Q, Xu L. N6-methyladenosine reader protein IGF2BP1 suppresses CD8 + T cells-mediated tumor cytotoxicity and apoptosis in colon cancer. Apoptosis. 2024;29:331\u201343. https:\/\/doi.org\/10.1007\/s10495-023-01893-7.","journal-title":"Apoptosis"},{"key":"2812_CR121","doi-asserted-by":"publisher","first-page":"914577","DOI":"10.3389\/fimmu.2022.914577","volume":"13","author":"G Yu","year":"2022","unstructured":"Yu G, Bao J, Zhan M, Wang J, Li X, Gu X, Song S, Yang Q, Liu Y, Wang Z, Xu B. Comprehensive analysis of m5C methylation regulatory genes and tumor microenvironment in prostate cancer. Front Immunol. 2022;13:914577. https:\/\/doi.org\/10.3389\/fimmu.2022.914577.","journal-title":"Front Immunol"},{"key":"2812_CR122","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41420-024-01862-2","volume":"10","author":"Q Meng","year":"2024","unstructured":"Meng Q, Xie Y, Sun K, He L, Wu H, Zhang Q, Liang T. ALYREF-JunD-SLC7A5 axis promotes pancreatic ductal adenocarcinoma progression through epitranscriptome-metabolism reprogramming and immune evasion. Cell Death Discov. 2024;10:97. https:\/\/doi.org\/10.1038\/s41420-024-01862-2.","journal-title":"Cell Death Discov"},{"key":"2812_CR123","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.70023","author":"J Jiang","year":"2025","unstructured":"Jiang J, Liu F, Cui D, Xu C, Chi J, Yan T, Guo F. Novel molecular mechanisms of immune evasion in hepatocellular carcinoma: NSUN2-mediated increase of SOAT2 RNA methylation. Cancer Commun (Lond). 2025. https:\/\/doi.org\/10.1002\/cac2.70023.","journal-title":"Cancer Commun (Lond)"},{"key":"2812_CR124","doi-asserted-by":"publisher","DOI":"10.1093\/gpbjnl\/qzae063","author":"Y Lu","year":"2024","unstructured":"Lu Y, Yang L, Feng Q, Liu Y, Sun X, Liu D, Qiao L, Liu Z. RNA 5-methylcytosine modification: regulatory molecules, biological functions, and human diseases. Genomics Proteomics Bioinform. 2024. https:\/\/doi.org\/10.1093\/gpbjnl\/qzae063.","journal-title":"Genomics Proteomics Bioinform"},{"key":"2812_CR125","doi-asserted-by":"publisher","first-page":"111533","DOI":"10.1016\/j.cellsig.2024.111533","volume":"127","author":"J Lai","year":"2025","unstructured":"Lai J, Chen L, Li Q, Zhao G, Li X, Guo D, Chen Z, Zhang Y, Fan J, Zhao H, Liang J, Tian L, Chen X, Lin J, Chen Q. tRNA methyltransferase DNMT2 promotes hepatocellular carcinoma progression and enhances Bortezomib resistance through inhibiting TNFSF10. Cell Signal. 2025;127:111533. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111533.","journal-title":"Cell Signal"},{"key":"2812_CR126","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s00262-025-03986-5","volume":"74","author":"Y Yang","year":"2025","unstructured":"Yang Y, Cao L, Xu X, Li D, Deng Y, Li L, Zeng B, Jiang H, Shan L, Huang Y, Xu Y, Ma L. NSUN2\/ALYREF axis-driven m(5)C methylation enhances PD-L1 expression and facilitates immune evasion in non-small-cell lung cancer. Cancer Immunol Immunother. 2025;74:132. https:\/\/doi.org\/10.1007\/s00262-025-03986-5.","journal-title":"Cancer Immunol Immunother"},{"key":"2812_CR127","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3233\/cbm-210154","volume":"33","author":"M Cui","year":"2022","unstructured":"Cui M, Qu F, Wang L, Liu X, Yu J. Tang Z and Cheng D m5C RNA methyltransferase-related gene NSUN4 stimulates malignant progression of hepatocellular carcinoma and can be a prognostic marker. Cancer Biomark. 2022;33:389\u2013400. https:\/\/doi.org\/10.3233\/cbm-210154.","journal-title":"Cancer Biomark"},{"key":"2812_CR128","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.21037\/tlcr-21-351","volume":"10","author":"H Chen","year":"2021","unstructured":"Chen H, Ge XL, Zhang ZY, Liu M, Wu RY, Zhang XF, Xu LP, Cheng HY, Sun XC, Zhu HC. M(5)C regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in lung adenocarcinoma. Transl Lung Cancer Res. 2021;10:2172\u201392. https:\/\/doi.org\/10.21037\/tlcr-21-351.","journal-title":"Transl Lung Cancer Res"},{"key":"2812_CR129","doi-asserted-by":"publisher","first-page":"e2404083","DOI":"10.1002\/advs.202404083","volume":"12","author":"H Han","year":"2025","unstructured":"Han H, Zhang C, Shi W, Wang J, Zhao W, Du Y, Zhao Z, Wang Y, Lin M, Qin L, Zhao X, Yin Q, Liu Y, Wang Z, Zhang J, You X, Zhou G, Wu H, Ye J, He X, Tian W, Yu H, Yuan Y, Wang Q. NSUN5 facilitates hepatocellular carcinoma progression by increasing SMAD3 expression. Adv Sci (Weinh). 2025;12:e2404083. https:\/\/doi.org\/10.1002\/advs.202404083.","journal-title":"Adv Sci (Weinh)"},{"key":"2812_CR130","doi-asserted-by":"publisher","first-page":"e23749","DOI":"10.1002\/jbt.23749","volume":"38","author":"Y Cui","year":"2024","unstructured":"Cui Y, Lv P, Zhang C. NSUN6 mediates 5-methylcytosine modification of METTL3 and promotes colon adenocarcinoma progression. J Biochem Mol Toxicol. 2024;38:e23749. https:\/\/doi.org\/10.1002\/jbt.23749.","journal-title":"J Biochem Mol Toxicol"},{"key":"2812_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-025-03411-2","author":"H Huang","year":"2025","unstructured":"Huang H, Fang L, Zhu C, Lv J, Xu P, Chen Z, Zhang Z, Wang J, Wang W, Xu Z. YBX1 promotes 5-Fluorouracil resistance in gastric cancer via m5C-dependent ATG9A mRNA stabilization through autophagy. Oncogene. 2025. https:\/\/doi.org\/10.1038\/s41388-025-03411-2.","journal-title":"Oncogene"},{"key":"2812_CR132","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13046-025-03368-w","volume":"44","author":"J Qi","year":"2025","unstructured":"Qi J, Jiang T, Liu B, Hu Q, Chen J, Ma N, Xu Y, Song H, Song J. LINC02167 stabilizes KSR1 mRNA in an m(5)C-dependent manner to regulate the ERK\/MAPK signaling pathway and promotes colorectal cancer metastasis. J Exp Clin Cancer Res. 2025;44:121. https:\/\/doi.org\/10.1186\/s13046-025-03368-w.","journal-title":"J Exp Clin Cancer Res"},{"key":"2812_CR133","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076109","author":"RA Zimmermann","year":"2023","unstructured":"Zimmermann RA, Fischer TR, Schwickert M, Nidoieva Z, Schirmeister T, Kersten C. Chemical space virtual screening against hard-to-drug RNA methyltransferases DNMT2 and NSUN6. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24076109.","journal-title":"Int J Mol Sci"},{"key":"2812_CR134","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.7150\/thno.104441","volume":"15","author":"D Jian","year":"2025","unstructured":"Jian D, Cheng X, Qi D, Wang S, Wang C, Shi Y, Li Z, Jin S, Jia Z, Teng P, Pei Z, Gu X, Jian L, Wang W, Yi X, Xing J, Tang H. Nsun2 controls cardiac homeostasis and hypertrophic response by regulating PRKACA expression. Theranostics. 2025;15:2393\u2013412. https:\/\/doi.org\/10.7150\/thno.104441.","journal-title":"Theranostics"},{"key":"2812_CR135","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12017-024-08823-z","volume":"27","author":"G Yan","year":"2025","unstructured":"Yan G, Xu Y, Xing X, Chen S, Li F. NSUN2-mediated RNA 5-methylcytosine modification of PTEN regulates cognitive impairments of mice with sleep deprivation and autophagy through PI3K\/AKT signaling. Neuromolecular Med. 2025;27:4. https:\/\/doi.org\/10.1007\/s12017-024-08823-z.","journal-title":"Neuromolecular Med"},{"key":"2812_CR136","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.7150\/thno.104713","volume":"15","author":"X Hou","year":"2025","unstructured":"Hou X, Dong Q, Hao J, Liu M, Ning J, Tao M, Wang Z, Guo F, Huang D, Shi X, Gao M, Li D, Zheng X. NSUN2-mediated m(5)C modification drives alternative splicing reprogramming and promotes multidrug resistance in anaplastic thyroid cancer through the NSUN2\/SRSF6\/UAP1 signaling axis. Theranostics. 2025;15:2757\u201377. https:\/\/doi.org\/10.7150\/thno.104713.","journal-title":"Theranostics"},{"key":"2812_CR137","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1038\/s41388-022-02325-7","volume":"41","author":"SY Chen","year":"2022","unstructured":"Chen SY, Chen KL, Ding LY, Yu CH, Wu HY, Chou YY, Chang CJ, Chang CH, Wu YN, Wu SR, Hou YC, Lee CT, Chen PC, Shan YS, Huang PH. RNA bisulfite sequencing reveals NSUN2-mediated suppression of epithelial differentiation in pancreatic cancer. Oncogene. 2022;41:3162\u201376. https:\/\/doi.org\/10.1038\/s41388-022-02325-7.","journal-title":"Oncogene"},{"key":"2812_CR138","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cpan.2024.12.002","volume":"21","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhang S, Liu K, Hu X, Gu X. Advances in drug discovery based on network pharmacology and omics technology. Curr Pharm Anal. 2024;21:33\u201343. https:\/\/doi.org\/10.1016\/j.cpan.2024.12.002.","journal-title":"Curr Pharm Anal"},{"key":"2812_CR139","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00432-002-0386-6","volume":"128","author":"H Yahata","year":"2002","unstructured":"Yahata H, Kobayashi H, Kamura T, Amada S, Hirakawa T, Kohno K, Kuwano M, Nakano H. Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer. J Cancer Res Clin Oncol. 2002;128:621\u20136. https:\/\/doi.org\/10.1007\/s00432-002-0386-6.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2812_CR140","doi-asserted-by":"publisher","first-page":"217064","DOI":"10.1016\/j.canlet.2024.217064","volume":"597","author":"H Meng","year":"2024","unstructured":"Meng H, Miao H, Zhang Y, Chen T, Yuan L, Wan Y, Jiang Y, Zhang L, Cheng W. YBX1 promotes homologous recombination and resistance to platinum-induced stress in ovarian cancer by recognizing m5C modification. Cancer Lett. 2024;597:217064. https:\/\/doi.org\/10.1016\/j.canlet.2024.217064.","journal-title":"Cancer Lett"},{"key":"2812_CR141","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41568-019-0168-y","volume":"19","author":"F Zanconato","year":"2019","unstructured":"Zanconato F, Cordenonsi M, Piccolo S. YAP and TAZ: a signalling hub of the tumour microenvironment. Nat Rev Cancer. 2019;19:454\u201364. https:\/\/doi.org\/10.1038\/s41568-019-0168-y.","journal-title":"Nat Rev Cancer"},{"key":"2812_CR142","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41417-022-00533-7","volume":"30","author":"W Yu","year":"2023","unstructured":"Yu W, Zhang C, Wang Y, Tian X, Miao Y, Meng F, Ma L, Zhang X, Xia J. YAP 5-methylcytosine modification increases its mRNA stability and promotes the transcription of exosome secretion-related genes in lung adenocarcinoma. Cancer Gene Ther. 2023;30:149\u201362. https:\/\/doi.org\/10.1038\/s41417-022-00533-7.","journal-title":"Cancer Gene Ther"},{"key":"2812_CR143","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 2020;17:807\u201321. https:\/\/doi.org\/10.1038\/s41423-020-0488-6.","journal-title":"Cell Mol Immunol"},{"key":"2812_CR144","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/s41591-019-0499-y","volume":"25","author":"C Segovia","year":"2019","unstructured":"Segovia C, San Jos\u00e9-En\u00e9riz E, Munera-Maravilla E, Mart\u00ednez-Fern\u00e1ndez M, Garate L, Miranda E, Vilas-Zornoza A, Lodewijk I, Rubio C, Segrelles C, Valc\u00e1rcel LV, Rabal O, Casares N, Bernardini A, Suarez-Cabrera C, L\u00f3pez-Calder\u00f3n FF, Fortes P, Casado JA, Due\u00f1as M, Villacampa F, Lasarte JJ, Guerrero-Ramos F, de Velasco G, Oyarzabal J, Castellano D, Agirre X, Pr\u00f3sper F, Paramio JM. Inhibition of a G9a\/DNMT network triggers immune-mediated bladder cancer regression. Nat Med. 2019;25:1073\u201381. https:\/\/doi.org\/10.1038\/s41591-019-0499-y.","journal-title":"Nat Med"},{"key":"2812_CR145","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1038\/s41467-019-11911-5","volume":"10","author":"F Zhang","year":"2019","unstructured":"Zhang F, Parayath NN, Ene CI, Stephan SB, Koehne AL, Coon ME, Holland EC, Stephan MT. Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers. Nat Commun. 2019;10:3974. https:\/\/doi.org\/10.1038\/s41467-019-11911-5.","journal-title":"Nat Commun"},{"key":"2812_CR146","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cell.2024.11.007","volume":"188","author":"Z Chen","year":"2025","unstructured":"Chen Z, Zeng C, Yang L, Che Y, Chen M, Sau L, Wang B, Zhou K, Chen Y, Qing Y, Shen C, Zhang T, Wunderlich M, Wu D, Li W, Wang K, Leung K, Sun M, Tang T, He X, Zhang L, Swaminathan S, Mulloy JC, M\u00fcschen M, Huang H, Weng H, Xiao G, Deng X, Chen J. YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies. Cell. 2025;188:331-351.e30. https:\/\/doi.org\/10.1016\/j.cell.2024.11.007.","journal-title":"Cell"},{"key":"2812_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2025.04.003","author":"S Xiao","year":"2025","unstructured":"Xiao S, Duan S, Caligiuri MA, Ma S, Yu J. YTHDF2: a key RNA reader and antitumor target. Trends Immunol. 2025. https:\/\/doi.org\/10.1016\/j.it.2025.04.003.","journal-title":"Trends Immunol"},{"key":"2812_CR148","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41419-023-06241-w","volume":"14","author":"B Chen","year":"2023","unstructured":"Chen B, Hong Y, Zhai X, Deng Y, Hu H, Tian S, Zhang Y, Ren X, Zhao J, Jiang C. m6A and m5C modification of GPX4 facilitates anticancer immunity via STING activation. Cell Death Dis. 2023;14:809. https:\/\/doi.org\/10.1038\/s41419-023-06241-w.","journal-title":"Cell Death Dis"},{"key":"2812_CR149","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.cmet.2023.07.009","volume":"35","author":"T Chen","year":"2023","unstructured":"Chen T, Xu ZG, Luo J, Manne RK, Wang Z, Hsu CC, Pan BS, Cai Z, Tsai PJ, Tsai YS, Chen ZZ, Li HY, Lin HK. NSUN2 is a glucose sensor suppressing cGAS\/STING to maintain tumorigenesis and immunotherapy resistance. Cell Metab. 2023;35:1782-1798.e8. https:\/\/doi.org\/10.1016\/j.cmet.2023.07.009.","journal-title":"Cell Metab"},{"key":"2812_CR150","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210279","author":"S Ma","year":"2021","unstructured":"Ma S, Yan J, Barr T, Zhang J, Chen Z, Wang LS, Sun JC, Chen J, Caligiuri MA, Yu J. The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity. J Exp Med. 2021. https:\/\/doi.org\/10.1084\/jem.20210279.","journal-title":"J Exp Med"},{"key":"2812_CR151","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1101\/gr.266551.120","volume":"31","author":"R Vaisvila","year":"2021","unstructured":"Vaisvila R, Ponnaluri VKC, Sun Z, Langhorst BW, Saleh L, Guan S, Dai N, Campbell MA, Sexton BS, Marks K, Samaranayake M, Samuelson JC, Church HE, Tamanaha E, Corr\u00eaa IR Jr, Pradhan S, Dimalanta ET, Evans TC, Williams L, Davis TB. Enzymatic methyl sequencing detects DNA methylation at single-base resolution from picograms of DNA. Genome Res. 2021;31:1280\u20139. https:\/\/doi.org\/10.1101\/gr.266551.120.","journal-title":"Genome Res"},{"key":"2812_CR152","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab033","author":"C Farrell","year":"2021","unstructured":"Farrell C, Thompson M, Tosevska A, Oyetunde A, Pellegrini M. BiSulfite Bolt: A bisulfite sequencing analysis platform. Gigascience. 2021. https:\/\/doi.org\/10.1093\/gigascience\/giab033.","journal-title":"Gigascience"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02812-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02812-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02812-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:56:19Z","timestamp":1750467379000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02812-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":152,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2812"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02812-z","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,21]]},"assertion":[{"value":"10 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"503"}}